Neumora Therapeutics, Inc. (NMRA)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 9.81 |
| 開市 | 9.60 |
| 買盤 | 9.39 x 200 |
| 賣出價 | 9.44 x 100 |
| 今日波幅 | 9.13 - 9.81 |
| 52 週波幅 | 8.82 - 21.00 |
| 成交量 | |
| 平均成交量 | 611,550 |
| 市值 | 1.503B |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.63 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 25.25 |
ZacksBiotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
Regeneron (REGN) and Sage Therapeutics (SAGE) are in focus on regulatory and pipeline updates.
ZacksNeumora (NMRA) Down on FDA Clinical Hold on Neurology Drug
The FDA places a clinical hold on Neumora's (NMRA) phase I study evaluating NMRA-266 for some types of neuropsychiatric disorders. Shares of the company fall on the news.
Investor's Business DailyNeumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
Neumora said Monday the FDA put its schizophrenia drug on hold after rabbits experienced convulsions, and the biotech stock plunged.
